Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, et al: A metagenome-wide association study of gut microbiota in type 2 diabetes
McCutcheon A
These are all things we dont know the answer to, he says
So that is one trend
Split dosing may make sense for some people since NAC does not stay active in the body for very long
Recently, Eli Lilly reported they anticipate submitting Orforglipron for FDA approval in the second half of 2025, with potential availability shortly after if approved